Scienture (NASDAQ:SCNX) Shares Up 1.1% – Still a Buy?

Scienture Holdings, Inc. (NASDAQ:SCNX)’s share price shot up 1.1% on Friday . The stock traded as high as $1.10 and last traded at $0.7760. 19,546,471 shares were traded during mid-day trading, an increase of 223% from the average session volume of 6,050,842 shares. The stock had previously closed at $0.7677.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently weighed in on the company. Wall Street Zen lowered Scienture from a “hold” rating to a “sell” rating in a research note on Sunday, August 17th. Weiss Ratings reiterated a “sell (d)” rating on shares of Scienture in a research report on Wednesday, October 8th. One analyst has rated the stock with a Sell rating, According to MarketBeat, the company currently has a consensus rating of “Sell”.

Scienture Trading Up 1.1%

The stock has a market capitalization of $16.40 million, a P/E ratio of -0.29 and a beta of 3.11. The company has a debt-to-equity ratio of 0.02, a current ratio of 0.11 and a quick ratio of 0.11. The firm’s 50 day moving average price is $0.90 and its 200 day moving average price is $1.15.

Scienture (NASDAQ:SCNX) last announced its quarterly earnings results on Tuesday, August 12th. The company reported ($0.48) earnings per share (EPS) for the quarter. Scienture had a negative net margin of 10,364.22% and a negative return on equity of 24.47%.

Scienture Company Profile

Scienture Holdings, Inc engages in the provision of health services and pharmaceutical products. It focuses on addressing underserved patients and indications through novel product concepts and innovation. The company was founded on July 15, 2005 and is headquartered in Lutz, FL.